Sustained Virological Response After Only 5 Weeks Treatment With Daclatasvir/Pegylated Interferon and Ribavirin as Part of a Clinical Trial in a Cirrhotic Human Immunodeficiency Virus (HIV) - Hepatitis C Virus (HCV) Co-Infected Patient With Liver Decompensation During Treatment
Journal of AIDS and HIV Research
doi 10.5897/jahr2015.0329
Full Text
Open PDFAbstract
Available in full text
Date
March 31, 2015
Authors
Publisher
Academic Journals